The Avicenna Alliance represents a collaborative effort among stakeholders committed to advancing in silico medicine. This initiative harnesses the power of computer modelling and simulation to revolutionize the development and delivery of innovative medical treatments.
AA
Avicenna Alliance
NGO · Belgium · EU Transparency Register 217362043770-33not in register snapshot
This register number is the organization’s own declaration on its submission. It is not in the 2 Sept 2026 snapshot of the EU Transparency Register, so we neither link to it nor use it to identify this organization.
5
positions filed
in the 583 files tracked
2
legislative files
of 583 tracked
2
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Track Avicenna in PolicySpeak: request access →
Work at Avicenna Alliance? so we know who speaks for it.
Their record over time
Avicenna Alliance filed 5 positions between 3 Feb 2021 and 6 Nov 2023, across 2 of the 583 legislative files tracked here, attaching a full position paper 2 times.
2021 · 2 filed2022 · 1 filed2023 · 2 filed
What they argued
The Avicenna Alliance represents a collaborative effort among stakeholders committed to advancing in silico medicine. This initiative harnesses the power of computer modelling and simulation to revolutionize the development and delivery of innovative medical treatments.
The Avicenna Alliance supports the Commission’s ambition to revise the EU’s general pharmaceuticals legislation as it represents an ideal opportunity to update the regulatory framework to reflect the uptake of new technologies, including in silico technologies such as Computer Modelling and Simulation (CM&S), for medicinal products including combination products and Advanced therapy medicinal products (ATMPs). 1.
The Avicenna Alliance welcomes the proposal for the EHDS. The Alliance is a multistakeholder group with the mission of accelerating medical innovation and its practical implementation to ensure safe, affordable and cost-effective health care through the large-scale adoption of in silico medicine and computer modelling and simulation (CM&S).
The European Health Data Space (EHDS) covering the exchange and access of primary and secondary use of good quality health data is eagerly awaited by the Avicenna Alliance to pursue scientific research and innovations, including the use of computer modelling and simulation (CM&S) in healthcare.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Avicenna Alliance next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Showing 5 of 57.
Is this your organization?
Everything on this page comes from Avicenna Alliance’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.